Abstract

Antimicrobial resistance is a slow-growing phenomenon that could even be a reason for a future pandemic. Due to inappropriate diagnosis and consumption of antibiotics, the bacteria have become resistant to the antibiotics used. In the era of COVID-19, this blind consumption of antibiotics has rapidly increased due to the period of quarantine and fear of the disease. Ligue to the fear of the pandemic, especially in ru, rural areas, many patients avoid going to the hospital and consuming antibiotics without any prescription. Various retrospective studies have shown a relationship between bacterial co-infection and AMR, which is increased in the era of COVID-19. Also, the secondary bacterial infections associated with the pandemic of COVID-19 have added to the risk of antimicrobial resistance. The viral effect on the respiratory system is favorable for bacterial infection, as in the case of COVID-19 affecting the respiratory tract followed by co-bacterial infection in some cases. COVID-19 has affected AMR in many aspects. Proper antibiotic resistance tests should be performed before prescribing any antibiotics to the patient to reduce the chances of AMR, especially in such an obnoxious situation of COVID-19. This crucially calls for a brand new and effective plan of action to attenuate the influence of the pandemic on antimicrobial resistance. Statistics of various countries in matters of antimicrobial resistance have shown an increase in AMR due to the concentration of health workers, researchers, and population on the pandemic associated with COVID-19. This calls for the necessity to aware the population worldwide about antimicrobial resistance and how it could be a hidden menace in the future and could probably prove to be a matter of concern as it would worsen the condition of the patients in a particular disease and would decrease the various possible aspects of the treatment especially in case of treatment based on antibiotics.

Highlights

  • Antimicrobial resistance(AMR) is seen to be emerging as a threat to effective prevention and treatment in the 21st century [1]

  • The viral effect on the respiratory system is favorable for bacterial infection, as in the case of COVID-19 affecting the respiratory tract followed by cobacterial infection in some cases

  • The obnoxious situation that we are hit with, the COVID-19 is reported to be contributing to the risk of antimicrobial resistance through medical management, the reported cases of secondary bacterial infections associated with COVID-19 are less as compared to the reports of usage of the antibiotics when treating COVID -19 patient [4]

Read more

Summary

INTRODUCTION

Antimicrobial resistance(AMR) is seen to be emerging as a threat to effective prevention and treatment in the 21st century [1]. In patients of covid 19, bacterial co-infections associated with COVID-19 have been reported, which will add up to the possibility of increased antimicrobial resistance [3]. According to a retrospective study done at Wuhan Union Hospital, it was found that bacterial co-infections were associated with the severity in the case of patients hospitalized. A retrospective cohort analysis conducted at a Barcelona hospital proved to be crucial in determining the role of empiric antimicrobial therapy and stewardship efforts [7]. Another retrospective case series of confirCOVID-positive time patients at the UK furthering the first wave of COVID-19 reports low levels of secondary bacterial infection in preliminary COVID-19 hospital presentations [8]. One-fifth of the participants were assured with the myth that antibiotics treat the common cold more effectively [12]

Staphylococcus aureus
NTS- non-typhoidal salmonella
Various Aspects in which COVID-19 Impacts AMR
Antibiotic Selection Difficulties for COVID-19 Victims in LMI
Strategies to Attenuate Consequence of COVID-19 on AMR
Monitoring AMR in the Era of Covid19: A Challenge
Antimicrobial Stewardship Program and COVID-19
Statistics and Facts
COMBINED EFFECTS OF BACTERIAL AND VIRAL PATHOGENS
Access of Antimicrobials
Antimicrobial use in COVID-19 Patients
CONCLUSION
ETHICAL APPROVAL
Findings
14. Centers for Disease Control and infection: survey of 568 UK general
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call